Stay updated on SAGE-217 Safety in MDD Insomnia Clinical Trial

Sign up to get notified when there's something new on the SAGE-217 Safety in MDD Insomnia Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SAGE-217 Safety in MDD Insomnia Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.1 to v3.3.2; no changes to study content, locations, or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T16:48:33.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision label updated from Revision: v3.2.0 to Revision: v3.3.1 on the page footer; otherwise study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T13:35:58.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    A funding/operating-status notice was removed from the page. This change eliminates a general operational update and does not alter the study details or eligibility.
    Difference
    0.3%
    Check dated 2025-11-17T06:27:31.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The sponsor of the study changed from Sage Therapeutics to Biogen, and Biogen is now listed as the sponsor and responsible party. Related sections such as the official title and sponsor information reflect Biogen’s involvement.
    Difference
    0.4%
    Check dated 2025-11-03T01:10:57.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Upgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.
    Difference
    2%
    Check dated 2025-10-05T09:32:57.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Added a new version tag (v3.1.0) and removed several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) from the page.
    Difference
    0.2%
    Check dated 2025-09-28T03:08:15.000Z thumbnail image

Stay in the know with updates to SAGE-217 Safety in MDD Insomnia Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SAGE-217 Safety in MDD Insomnia Clinical Trial page.